Fosamax and Femor Fractures Reported by the FDA - Consumer Justice Foundation

Fosamax and Femor Fractures Reported by the FDA

Written by Andrew Sarski on April 2, 2011
Consumer Justice Foundation Seal

Fosamax and Femor Fractures Reported by the FDA

The FDA is reporting increased femore fractures with the use of certain osteoporosis drugs and bisphosphate drugs including Fosamax.

 

10-13-2010 The U.S. Food and Drug Administration (FDA) is updating the public regarding information previously communicated describing the risk of atypical fractures of the thigh, known as subtrochanteric and diaphyseal femur fractures, in patients who take bisphosphonates for osteoporosis.  This information will be added to the Warnings and Precautions section of the labels of all bisphosphonate drugs approved for the prevention or treatment of osteoporosis.

Posted Under: FDA - Food and Drug Administration
Start Claim Now
Do you deserve compensation?

An attorney will review your situation for FREE and help you found out what really went wrong.

How Can We Reach You?

Please Explain Your Situation

By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.
×